Gordian Capital (Singapore)’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1
Closed -$4 134
2023
Q2
$4 Hold
1
﹤0.01% 127
2023
Q1
$1K Hold
1
﹤0.01% 68
2022
Q4
$1K Hold
1
﹤0.01% 70
2022
Q3
$1K Hold
1
﹤0.01% 79
2022
Q2
$1K Sell
1
-9
-90% -$65 ﹤0.01% 91
2022
Q1
$1K Buy
+10
New +$70 ﹤0.01% 109

Other funds holding SRTA

Gordian Capital (Singapore)'s SRTA Position: Q3 2023 in Review

Gordian Capital (Singapore) sold out of Strata Critical Medical Inc (SRTA) in Q3 2023, closing a stake of 1 share — an estimated $4 sold.

Gordian Capital (Singapore) first reported a position in SRTA in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q1 2023. 105 funds tracked by Wall St. Rank hold SRTA as of Q3 2023.

  • Gordian Capital (Singapore) reported no remaining Strata Critical Medical Inc position as of Q3 2023 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 1 Strata Critical Medical Inc share in Q3 2023, an estimated $4.
  • Gordian Capital (Singapore) first reported a position in Strata Critical Medical Inc in Q1 2022 and held it in 6 quarters.
  • Gordian Capital (Singapore)'s Strata Critical Medical Inc position peaked at $1K in Q1 2023.
  • 105 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2023.

Based on Gordian Capital (Singapore)'s 13F filing for Q3 2023, filed 14 Nov 2023.